Charles Schwab Investment Management Inc Homology Medicines, Inc. Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.55 - $3.01 $34,055 - $66,132	21,971 New	21,971 $36,000
Q2 2022 Aug 15, 2022	SELL	$1.39 - $3.12 $155,545 - $349,137	-111,903 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.6 - $4.17 $6,523 - $10,462	2,509 Added 2.29%	111,903 $341,000
Q3 2021 Nov 16, 2021	SELL	$6.01 - $8.71 $1.16 Million - $1.68 Million	-192,952 Reduced 63.82%	109,394 $861,000
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $540,391 - $865,344	89,766 Added 42.23%	302,346 $2.2 Million

Q1 2021 May 17, 2021	SELL	$9.17 - $14.8 $98,394 - $158,804	-10,730 Reduced 4.8%	212,580 $2 Million
Q4 2020 Feb 16, 2021	BUY	$8.92 - $13.29 $15,627 - $23,284	1,752 Added 0.79%	223,310 $2.52 Million
Q3 2020 Nov 13, 2020	BUY	$9.94 - $16.59 $342,621 - $571,840	34,469 Added 18.42%	221,558 $2.37 Million
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $396,704 - $635,647	32,867 Added 21.31%	187,089 $2.84 Million
Q1 2020 May 15, 2020	BUY	$12.5 - $22.04 $33,975 - $59,904	2,718 Added 1.79%	154,222 $2.4 Million
Q4 2019 Feb 07, 2020	BUY	$11.42 - $22.19 $31,016 - $60,268	2,716 Added 1.83%	151,504 $3.14 Million
Q3 2019 Nov 08, 2019	BUY	$14.74 - $22.28 $46,033 - $69,580	3,123 Added 2.14%	148,788 $2.69 Million
Q2 2019 Aug 09, 2019	BUY	$18.35 - $30.34 $1.41 Million - $2.33 Million	76,644 Added 111.04%	145,665 $2.85 Million
Q1 2019 May 14, 2019	BUY	$19.76 - $29.57 $46,119 - $69,016	2,334 Added 3.5%	69,021 $1.91 Million
Q4 2018 Feb 14, 2019	BUY	$18.39 - $26.3 $224,633 - $321,254	12,215 Added 22.42%	66,687 $1.49 Million
Q3 2018 Nov 13, 2018	BUY	$15.54 - $22.86 $86,340 - $127,010	5,556 Added 11.36%	54,472 $1.25 Million
Q2 2018 Aug 08, 2018	BUY	$16.49 - $21.55 $806,624 - $1.05 Million	48,916 New	48,916 $998,000

Others Institutions Holding FIXX

# of Institutions

Shares Held

66.2K

Call Options Held

Put Options Held

View Full List

About Homology Medicines, Inc.

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

More about FIXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account